FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Macleods Pharma Pioglitazone and Metformin Hydrochloride Recall

Pioglitazone and Metformin Hydrochloride Tablets, USP 15 mg/500 mg, Rx Only, 60-count b…

Macleods Pharma Usa Inc · Plainsboro, NJ

Risk level
Class III
Reported by FDA
Feb 12, 2020
Recall ID
D-0838-2020
Check your lot numberHow we source this data

Summary

Macleods Pharma recalled Pioglitazone and Metformin Hydrochloride starting Jan 24, 2020. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0838-2020 on Feb 12, 2020. Reason: Subpotent Drug: Out of specification assay result, below specification, for two lots of Pioglitazone And Metformin Hydrochloride Tablets. Status: Terminated.

Why it was recalled

Subpotent Drug: Out of specification assay result, below specification, for two lots of Pioglitazone And Metformin Hydrochloride Tablets.

Product description

Pioglitazone and Metformin Hydrochloride Tablets, USP 15 mg/500 mg, Rx Only, 60-count bottle, Manufactured for Macleods Pharma USA, Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, India, NDA 33342-176-09

Lot numbers, UPCs & expiration codes

Lot# BPA5903A, EXP 05/2021; BPA5819A, EXP 11/2020

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0838-2020
Classification
Class III
Status
Terminated
Recall initiated
Jan 24, 2020
FDA report date
Feb 12, 2020
Quantity
4694 30x60-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Macleods Pharma Usa Inc

Original FDA data

Every field from FDA enforcement report D-0838-2020, exactly as published.

Show all FDA fields
City
Plainsboro
State
NJ
Status
Terminated
Country
United States
Event ID
84754
Address
666 Plainsboro Rd Bldg 200 Ste 230
Code information
Lot# BPA5903A, EXP 05/2021; BPA5819A, EXP 11/2020
Postal code
08536-0009
Report date
Feb 12, 2020
Product type
Drugs
Recall number
D-0838-2020
Classification
Class III
Recalling firm
Macleods Pharma Usa Inc
Product quantity
4694 30x60-count bottles
Termination date
Dec 16, 2022
Reason for recall
Subpotent Drug: Out of specification assay result, below specification, for two lots of Pioglitazone And Metformin Hydrochloride Tablets.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Pioglitazone and Metformin Hydrochloride Tablets, USP 15 mg/500 mg, Rx Only, 60-count bottle, Manufactured for Macleods Pharma USA, Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, India, NDA 33342-176-09
Distribution pattern
Nationwide
Recall initiation date
Jan 24, 2020
Initial firm notification
Letter
Center classification date
Feb 11, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0838-2020, published Feb 12, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls